Healthy Skepticism Library item: 5534
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: news
Drug labeling in developing countries
1993 Feb
Abstract:
A study by the Office of Technology Assessment of the U.S. Congress found that the label and package inserts for at least half of a sample of 241 products sold by U.S.-based companies in four countries-Brazil, Kenya, Panama and Thailand-failed to provide sufficient information for doctors to use the drugs safely and effectively. The OTA report offers the U.S. government several policy options.
Keywords:
*analytic survey/*government report/Brazil/Kenya/Panama/Thailand/OTA/Office of Technology Assessment/United States/International Federation of Pharmaceutical Manufacturers Associations/IFPMA/developing countries/labeling/package inserts/Food and Drug Administration/FDA/WHO/World Health Organization/EVALUATION OF PROMOTION: COMMERCIAL DRUG COMPENDIA/EVALUATION OF PROMOTION: COMPARISON BETWEEN DEVELOPING AND DEVELOPED COUNTRIES/EVALUATION OF PROMOTION: LABELLING AND PACKAGE INSERTS/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/REGULATION, CODES, GUIDELINES: DIRECT GOVERNMENT REGULATION/REGULATION, CODES, GUIDELINES: INTERNATIONAL CODES
